All In MedTech

Device Trial Radar · NCT07468617

Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Jan 2, 2027

Primary completion

Apr 1, 2027

Study completion May 31, 2027

Sponsor

Lead sponsor
CSA Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 12, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to determine the safety of repeat metered cryospray (MCS) treatment in patients with COPD with chronic bronchitis previously treated with MCS.

Conditions

  • COPD (Chronic Obstructive Pulmonary Disease)
  • Chronic Bronchitis

Interventions

  • Metered cryospray (MCS)Device

    Bronchial metered cryospray (MCS)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Completed MCS treatment applicationsTime frame: Treatment 1 and Treatment 2

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.